EcoDrugPlus

Matrix Metallopeptidase 8

Ensembl ID : ENSBGRG00000018057
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSBGRG00000020450
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSBGRG00000010134
Gene Symbol: MTOR
1 Cross references
224 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSBGRG00000011613
Gene Symbol: MC3R
1 Cross references
137 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSBGRG00000016023
Gene Symbol: MC4R
1 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSBGRG00000016011
Gene Symbol: MTNR1A
1 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSBGRG00000016629
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSBGRG00000009643
Gene Symbol: MME
1 Cross references
234 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSBGRG00000000711
Gene Symbol: METAP2
1 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSBGRG00000020032
Gene Symbol: MAPT
1 Cross references
226 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSBGRG00000024728
Gene Symbol: MAPK1
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSBGRG00000017007
Gene Symbol: MAPK10
1 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).